IXC 6.67% 8.0¢ invex therapeutics ltd

Ann: Invex Granted Key European Patent for Exenatide, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 190 Posts.
    lightbulb Created with Sketch. 22
    Despite the obvious good news associated with the patent acquisition, it's the first time in ages that the company has actually bullishly sold itself.

    We keep burying the TAM, which is the most attractive part of this business, amidst all the regulatory news and updates.

    Management need to get back to selling the blue sky - those two sentences in the announcement around the European market are so powerful. More of it please!
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.